Mission Street and BGO sign latest tenant for Oxford science space
What Xyme, an AI-driven enzyme design company, has taken space at Inventa in OxfordWhy Mission Street and BGO opened the building last year, as the first purpose-built commercial science scheme in Oxford’s West EndWhat next Duo on site with 183,000 sq ft next phaseScience and innovation developer Mission Street and investment manager BGO have signed Xyme, an AI-driven enzyme design company, to…
Tristan backs £300m+ life sciences platform
Tristan Capital Partners’ debt fund has refinanced a £310m prime life science portfolio located across Cambridge and Oxford, Green Street News can reveal.
Mission Street and BGO get go-ahead for 23-acre central Cambridge science district
CAMBRIDGE, UK - In a significant step forward for the UK’s aspirations to be a ‘science superpower’, specialist investor, developer and operator for the science and innovation sector Mission Street and BGO, a leading global real estate investment manager, received planning consent to deliver a world-class 23-acre urban science district in central Cambridge.
Life sciences venture capital experts join Mission Street board
Peter Finan and Jonathan Hepple have extensive experience in the biotechnology industry
Mission Street lodges plans for £100m Oxford R&D hub
Scheme is to provide 182,900 sq ft of science and innovation workspace
Mission Street and BGO plot new Cambridge science district
Partners have purchased a 23 acre site for their lab space joint venture